Prognostic biomarker PSMD14 facilitates bladder cancer tumorigenesis and progression by regulating Nucleolin-YAP1 axis

Prognostic biomarker PSMD14 facilitates bladder cancer tumorigenesis and progression by regulating Nucleolin-YAP1 axis

Deubiquitinating enzymes (DUBs) significantly contribute to tumor progression and treatment resistance in bladder cancer. However, the mechanisms by which DUBs promote malignant behavior in patients with bladder cancer remain poorly understood. Using online databases such as TCGA, GSE13507, and GSE2...

Full description

Saved in:
Bibliographic Details
Main Authors: Yunfei Wu, Zhijie Xu, Runzhe Wang, Yanfeng Bai, Xiaoyi Chen, Cheng Cheng, Baiye Jin, Guanghou Fu
Format: Article
Language:English
Published: Elsevier 2025-05-01
Series:Translational Oncology
Subjects:
Bladder cancer
PSMD14
NCL
Progression
Online Access:http://www.sciencedirect.com/science/article/pii/S1936523325001019
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items